CellAction supported the launch of the THEODORA Project, coordinated by Institut Curie, focusing on process development activities for cell therapy approaches.
Published
Signal category
Partnerships
Quote
“support the launch of the THEODORA Project, coordinated by our institution, Institut Curie.”
— CellAction team
Company
CellAction
Cell therapy Acceleration and Innovation: Rethinking cell & gene therapy By Institut Curie
- Industry
- Research Services
- Company size
- 14 employees
CellAction (Cell therapy Acceleration and Innovation) is the cell and gene therapy platform of the Paris-Saclay Cancer Cluster (PSCC) at Institut Curie. A first in France, CellAction enables collaborative projects to be launched with industrial partners on a national and international scale. The aim is to accelerate the development of optimized cell and gene therapies. CellAction is founded on the centralization of key expertise required for the drug development process: - Institut Curie's highly qualified medical-scientific teams - Cutting-edge technologies for in vitro and in vivo testing - Experienced advisors on business development and processes. This integrated structure makes it possible to launch projects for the development of innovative cell and gene therapies, from basic research through to their transfer to the clinic and delivery to patients.
Founded 2024